279 related articles for article (PubMed ID: 25605253)
1. Selective inhibition of histone deacetylase 2 induces p53-dependent survivin downregulation through MDM2 proteasomal degradation.
Seo SK; Hwang CS; Choe TB; Hong SI; Yi JY; Hwang SG; Lee HG; Oh ST; Lee YH; Park IC
Oncotarget; 2015 Sep; 6(28):26528-40. PubMed ID: 25605253
[TBL] [Abstract][Full Text] [Related]
2. SAHA shows preferential cytotoxicity in mutant p53 cancer cells by destabilizing mutant p53 through inhibition of the HDAC6-Hsp90 chaperone axis.
Li D; Marchenko ND; Moll UM
Cell Death Differ; 2011 Dec; 18(12):1904-13. PubMed ID: 21637290
[TBL] [Abstract][Full Text] [Related]
3. DDX3 loss by p53 inactivation promotes tumor malignancy via the MDM2/Slug/E-cadherin pathway and poor patient outcome in non-small-cell lung cancer.
Wu DW; Lee MC; Wang J; Chen CY; Cheng YW; Lee H
Oncogene; 2014 Mar; 33(12):1515-26. PubMed ID: 23584477
[TBL] [Abstract][Full Text] [Related]
4. Oligomerization conditions Mdm2-mediated efficient p53 polyubiquitylation but not its proteasomal degradation.
Hjerpe R; Aillet F; Lopitz-Otsoa F; Lang V; Torres-Ramos M; Farrás R; Hay RT; Rodríguez MS
Int J Biochem Cell Biol; 2010 May; 42(5):725-35. PubMed ID: 20080206
[TBL] [Abstract][Full Text] [Related]
5. Epigallocatechin gallate promotes p53 accumulation and activity via the inhibition of MDM2-mediated p53 ubiquitination in human lung cancer cells.
Jin L; Li C; Xu Y; Wang L; Liu J; Wang D; Hong C; Jiang Z; Ma Y; Chen Q; Yu F
Oncol Rep; 2013 May; 29(5):1983-90. PubMed ID: 23483203
[TBL] [Abstract][Full Text] [Related]
6. Histone deacetylase 2 is involved in DNA damage-mediated cell death of human osteosarcoma cells through stimulation of the ATM/p53 pathway.
Sun D; Yu M; Li Y; Xing H; Gao Y; Huang Z; Hao W; Lu K; Kong C; Shimozato O; Ozaki T; Zhu Y
FEBS Open Bio; 2019 Mar; 9(3):478-489. PubMed ID: 30868056
[TBL] [Abstract][Full Text] [Related]
7. Histone deacetylase inhibitors sensitize human non-small cell lung cancer cells to ionizing radiation through acetyl p53-mediated c-myc down-regulation.
Seo SK; Jin HO; Woo SH; Kim YS; An S; Lee JH; Hong SI; Lee KH; Choe TB; Park IC
J Thorac Oncol; 2011 Aug; 6(8):1313-9. PubMed ID: 21642861
[TBL] [Abstract][Full Text] [Related]
8. 2-Methoxy-5((3,4,5-trimethosyphenyl)seleninyl) phenol inhibits MDM2 and induces apoptosis in breast cancer cells through a p53-independent pathway.
Xu J; Han M; Shen J; Guan Q; Bai Z; Lang B; Zhang H; Li Z; Zuo D; Zhang W; Wu Y
Cancer Lett; 2016 Dec; 383(1):9-17. PubMed ID: 27693458
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of LRRC8A protects human ovarian and alveolar carcinoma cells against Cisplatin-induced expression of p53, MDM2, p21Waf1/Cip1, and Caspase-9/-3 activation.
Sørensen BH; Nielsen D; Thorsteinsdottir UA; Hoffmann EK; Lambert IH
Am J Physiol Cell Physiol; 2016 Jun; 310(11):C857-73. PubMed ID: 26984736
[TBL] [Abstract][Full Text] [Related]
10. HDAC1 and HDAC2 integrate the expression of p53 mutants in pancreatic cancer.
Stojanovic N; Hassan Z; Wirth M; Wenzel P; Beyer M; Schäfer C; Brand P; Kroemer A; Stauber RH; Schmid RM; Arlt A; Sellmer A; Mahboobi S; Rad R; Reichert M; Saur D; Krämer OH; Schneider G
Oncogene; 2017 Mar; 36(13):1804-1815. PubMed ID: 27721407
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of HURP inhibits the proliferation of hepacellular carcinoma cells via downregulation of gankyrin and accumulation of p53.
Kuo TC; Chang PY; Huang SF; Chou CK; Chao CC
Biochem Pharmacol; 2012 Mar; 83(6):758-68. PubMed ID: 22230478
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA501-5p induces p53 proteasome degradation through the activation of the mTOR/MDM2 pathway in ADPKD cells.
de Stephanis L; Mangolini A; Servello M; Harris PC; Dell'Atti L; Pinton P; Aguiari G
J Cell Physiol; 2018 Sep; 233(9):6911-6924. PubMed ID: 29323708
[TBL] [Abstract][Full Text] [Related]
13. VPA inhibits breast cancer cell migration by specifically targeting HDAC2 and down-regulating Survivin.
Zhang L; Wang G; Wang L; Song C; Leng Y; Wang X; Kang J
Mol Cell Biochem; 2012 Feb; 361(1-2):39-45. PubMed ID: 21959976
[TBL] [Abstract][Full Text] [Related]
14. FKBP25, a novel regulator of the p53 pathway, induces the degradation of MDM2 and activation of p53.
Ochocka AM; Kampanis P; Nicol S; Allende-Vega N; Cox M; Marcar L; Milne D; Fuller-Pace F; Meek D
FEBS Lett; 2009 Feb; 583(4):621-6. PubMed ID: 19166840
[TBL] [Abstract][Full Text] [Related]
15. Ret finger protein 2 enhances ionizing radiation-induced apoptosis via degradation of AKT and MDM2.
Joo HM; Kim JY; Jeong JB; Seong KM; Nam SY; Yang KH; Kim CS; Kim HS; Jeong M; An S; Jin YW
Eur J Cell Biol; 2011 May; 90(5):420-31. PubMed ID: 21333377
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of Mdm2 and Mdm4 enhances viral gene expression during adenovirus infection.
Yang H; Zheng Z; Zhao LY; Li Q; Liao D
Cell Cycle; 2012 Feb; 11(3):582-93. PubMed ID: 22262167
[TBL] [Abstract][Full Text] [Related]
17. The Wip1 Phosphatase acts as a gatekeeper in the p53-Mdm2 autoregulatory loop.
Lu X; Ma O; Nguyen TA; Jones SN; Oren M; Donehower LA
Cancer Cell; 2007 Oct; 12(4):342-54. PubMed ID: 17936559
[TBL] [Abstract][Full Text] [Related]
18. MDM2 mediates fibroblast activation and renal tubulointerstitial fibrosis via a p53-independent pathway.
Ye C; Tang H; Zhao Z; Lei CT; You CQ; Zhang J; Gao P; He FF; Chen S; Wang YM; Zhang C; Su H
Am J Physiol Renal Physiol; 2017 Apr; 312(4):F760-F768. PubMed ID: 28100501
[TBL] [Abstract][Full Text] [Related]
19. The degradation of p53 and its major E3 ligase Mdm2 is differentially dependent on the proteasomal ubiquitin receptor S5a.
Sparks A; Dayal S; Das J; Robertson P; Menendez S; Saville MK
Oncogene; 2014 Sep; 33(38):4685-96. PubMed ID: 24121268
[TBL] [Abstract][Full Text] [Related]
20. cIAP2 represses IKKα/β-mediated activation of MDM2 to prevent p53 degradation.
Lau R; Niu MY; Pratt MA
Cell Cycle; 2012 Nov; 11(21):4009-19. PubMed ID: 23032264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
